Annual Cash & Cash Equivalents
$109.97 M
+$41.57 M+60.78%
December 31, 2023
Summary
- As of February 7, 2025, KYMR annual cash & cash equivalents is $109.97 million, with the most recent change of +$41.57 million (+60.78%) on December 31, 2023.
- During the last 3 years, KYMR annual cash & cash equivalents has risen by +$78.96 million (+254.68%).
- KYMR annual cash & cash equivalents is now at all-time high.
Performance
KYMR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$110.72 M
+$43.11 M+63.75%
September 30, 2024
Summary
- As of February 7, 2025, KYMR quarterly cash and cash equivalents is $110.72 million, with the most recent change of +$43.11 million (+63.75%) on September 30, 2024.
- Over the past year, KYMR quarterly cash and cash equivalents has increased by +$752.00 thousand (+0.68%).
- KYMR quarterly cash and cash equivalents is now -29.40% below its all-time high of $156.82 million, reached on September 30, 2021.
Performance
KYMR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KYMR Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +60.8% | +0.7% |
| 3 y3 years | +254.7% | +0.7% |
| 5 y5 years | +166.5% | +0.7% |
KYMR Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +129.2% | -28.9% | +228.2% |
| 5 y | 5-year | at high | +254.7% | -29.4% | +257.1% |
| alltime | all time | at high | +254.7% | -29.4% | +257.1% |
Kymera Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $110.72 M(+63.8%) |
| Jun 2024 | - | $67.61 M(-27.7%) |
| Mar 2024 | - | $93.51 M(-15.0%) |
| Dec 2023 | $109.97 M(+60.8%) | $109.97 M(+35.7%) |
| Sep 2023 | - | $81.05 M(+54.7%) |
| Jun 2023 | - | $52.39 M(+4.5%) |
| Mar 2023 | - | $50.15 M(-26.7%) |
| Dec 2022 | $68.39 M | $68.39 M(-56.1%) |
| Sep 2022 | - | $155.66 M(+102.4%) |
| Jun 2022 | - | $76.91 M(+128.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $33.73 M(-29.7%) |
| Dec 2021 | $47.98 M(+54.7%) | $47.98 M(-69.4%) |
| Sep 2021 | - | $156.82 M(+84.7%) |
| Jun 2021 | - | $84.90 M(+59.9%) |
| Mar 2021 | - | $53.10 M(+71.3%) |
| Dec 2020 | $31.00 M(-59.2%) | $31.00 M(-43.2%) |
| Sep 2020 | - | $54.59 M(-10.5%) |
| Jun 2020 | - | $60.97 M(-19.8%) |
| Dec 2019 | $76.02 M(+84.2%) | $76.02 M |
| Dec 2018 | $41.26 M | - |
FAQ
- What is Kymera Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Kymera Therapeutics?
- What is Kymera Therapeutics annual cash & cash equivalents year-on-year change?
- What is Kymera Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Kymera Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of KYMR is $109.97 M
What is the all time high annual cash & cash equivalents for Kymera Therapeutics?
Kymera Therapeutics all-time high annual cash & cash equivalents is $109.97 M
What is Kymera Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, KYMR annual cash & cash equivalents has changed by +$41.57 M (+60.78%)
What is Kymera Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of KYMR is $110.72 M
What is the all time high quarterly cash and cash equivalents for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly cash and cash equivalents is $156.82 M
What is Kymera Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, KYMR quarterly cash and cash equivalents has changed by +$752.00 K (+0.68%)